David Farrar, BSc

Extended Antibacterial Activity of Multi-Action Wound Treatment

Introduction: The aim of the study was to assess the antibacterial activity of a novel multi-action treatment (MAT*) over 24-hour and seven-day periods, reflecting the possible length of ...

Stephen C. Davis , BS, MS;

David Farrar , BSc;

Alexander Higa , MA;

Michael Solis , MBA;

Steven J. Kavros , DPM, MAPWCA, FACCWS;

Phillip Frost ;

05/26/2022

Protease Modulating Properties of Multi-Action Wound Treatment

Introduction: The aim of this study was to assess the capability of a novel Multi-Action Treatment (MAT*) dressing to modulate levels of Matrix Metalloproteinase (MMP-2 and MMP-9) and Neu...

Mengfan Wu , MD, PhD;

Zhen Yu , MD, PhD;

David Farrar , BSc;

Dennis P. Orgill , MD, PhD;

Valentin Huag , MD;

Brian Ng , BA;

Adriana Panayi , MD;

05/26/2022

Biofilm Disruption Activity of Multi-Action Wound Treatment

Introduction: The aim of this study was to assess the biofilm disruption activity of a novel multi-action treatment (MAT*) and a carboxymethylcellulose (CMC) gelling-fibre silver dressing...

Cerys Griffiths ;

Mike Perkins ;

David Farrar , BSc;

05/26/2022

Wound Closure Trajectories in Prospective Cohort Study of Lyopreserved Amniotic Membrane

The aims are twofold: to compare cellular viability between cryopreserved and lyopreserved constructs; and evaluate clinical outcomes of the lyopreserved amniotic membrane (LAM).

David Farrar , BSc;

Lawrence A. Lavery , DPM, MPH;

Zachary Berriman-Rozen ;

Matthew Malone , PhD;

Katherine Raspovic ;

01/28/2021

Assessment of the Biofilm Disruption Activity of Absorbent Sustained-action Dressing with Povidone Iodine

Abstract Body: Objective: Over 65% of bacterial infections treated in the developed world are known to include biofilms, which are less susceptible to host defences or conventional therap...

Stefania Fabbri ;

Hannah Thomas ;

Jean Pine ;

Chris Agboh , PhD;

Samantha J. Westgate , PhD;

Gillian Durkin ;

David Farrar , BSc;

Chris Marsden , PhD;

11/23/2020